The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Merck announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date of the supplemental ...
read more
Novavax, Inc. announced submission of its request to expand the conditional marketing authorization (CMA) of Nuvaxovid™ COVID-19 Vaccine (recombinant,...
read more
The Centers for Disease Control and Prevention (CDC) Nowcast data from March 29, 2022 estimates that the proportion of COVID-19 cases caused by the ...
read more
Wednesday, March 30, 2022
CVS Health has entered into an agreement with the State of Florida to resolve claims dating back more than a decade related to prescriptions for ...
read more
Wednesday, March 30, 2022
The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised...
read more
Wednesday, March 30, 2022
Collegium Pharmaceutical, Inc. announced the execution of a Master Settlement Agreement resolving all 27 pending opioid-related lawsuits brought ...
read more
Wednesday, March 30, 2022
Mapi Pharma Ltd. announced that the company has been granted U.S. Patent No. 11,167,003 entitled: “Methods for suppressing or alleviating primary or ...
read more
The U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President's fiscal year (FY) 2023 ...
read more
Santhera Pharmaceuticals (and ReveraGen BioPharma, Inc announced the initiation of a rolling new drug application (NDA) submission to the FDA for ...
read more
Australian biotech company Noxopharm announced the FDA granted Orphan Drug Designation (ODD) to Veyonda®, its lead oncology drug candidate, for use in...
read more
Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved a 2 mg dose of Ozempic® (semaglutide) injection, a once-weekly ...
read more
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorization in the ...
read more
Innovent Biologics, Inc. and Eli Lilly and Company announced that in light of both parties' shared commitment to continue bringing innovative ...
read more
Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ...
read more
Merck announced the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending ...
read more